- Home
- GPUS vs LSTA Comparison
GPUS vs LSTA Comparison
Compare GPUS & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPUS
- LSTA
- Stock Information
- Founded
- GPUS 1969
- LSTA 1980
- Country
- GPUS United States
- LSTA United States
- Employees
- GPUS N/A
- LSTA N/A
- Industry
- GPUS
- LSTA Misc Health and Biotechnology Services
- Sector
- GPUS
- LSTA Health Care
- Exchange
- GPUS NYSE
- LSTA Nasdaq
- Market Cap
- GPUS 20.7M
- LSTA 23.1M
- IPO Year
- GPUS 1996
- LSTA N/A
- Fundamental
- Price
- GPUS $0.66
- LSTA $2.49
- Analyst Decision
- GPUS
- LSTA Strong Buy
- Analyst Count
- GPUS 0
- LSTA 2
- Target Price
- GPUS N/A
- LSTA $23.50
- AVG Volume (30 Days)
- GPUS 3.1M
- LSTA 55.8K
- Earning Date
- GPUS 08-15-2025
- LSTA 08-07-2025
- Dividend Yield
- GPUS N/A
- LSTA N/A
- EPS Growth
- GPUS N/A
- LSTA N/A
- EPS
- GPUS N/A
- LSTA N/A
- Revenue
- GPUS $93,318,000.00
- LSTA $1,000,000.00
- Revenue This Year
- GPUS N/A
- LSTA N/A
- Revenue Next Year
- GPUS N/A
- LSTA N/A
- P/E Ratio
- GPUS N/A
- LSTA N/A
- Revenue Growth
- GPUS N/A
- LSTA N/A
- 52 Week Low
- GPUS $0.64
- LSTA $1.87
- 52 Week High
- GPUS $9.98
- LSTA $4.20
- Technical
- Relative Strength Index (RSI)
- GPUS N/A
- LSTA 44.42
- Support Level
- GPUS N/A
- LSTA $2.45
- Resistance Level
- GPUS N/A
- LSTA $2.80
- Average True Range (ATR)
- GPUS 0.00
- LSTA 0.21
- MACD
- GPUS 0.00
- LSTA -0.02
- Stochastic Oscillator
- GPUS 0.00
- LSTA 27.71
About GPUS HYPERSCALE DATA INC
Hyperscale Data Inc, formerly Ault Alliance Inc is a diversified holding company. It operates a data center at which it mines Bitcoin and provides mission-critical products that support a diverse range of industries, including oil exploration, crane services, defense/aerospace, industrial, automotive, medical/biopharma, consumer electronics, hotel operations and textiles. The company has six reportable segments: Energy and Infrastructure; Technology and Finance; Sentinum, Inc.; GIGA; TurnOnGreen; ROI; and Ault Global Real Estate Equities, Inc.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.